Cancer Clinical Trial
— EXERT-COfficial title:
EXERT-C: Prospective Study of an EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer
NCT number | NCT06083324 |
Other study ID # | 2023-021-SG |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | February 3, 2023 |
Est. completion date | May 3, 2024 |
This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements under close supervision on individuals who have been treated for cancer.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | May 3, 2024 |
Est. primary completion date | February 3, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 89 Years |
Eligibility | Inclusion Criteria: 1. Age 20-89 years 2. Women of child-bearing potential must verbally confirm lack of pregnancy prior to enrollment. They should also consent to use adequate contraception during the course of the study. 3. Participants must be determined capable of engaging in resistance training by exercise personnel and/or study PI 4. Participants must complete an assessment by EOC staff and be determined safe to engage in the workout regimen by the study exercise personnel. 5. Individuals not deemed safe to participate in the standard EOC exercise program will be referred to physical therapy or elsewhere Exclusion Criteria: 1. Severe arthritic, joint, cardiovascular, or musculoskeletal condition that would interfere with exercise program |
Country | Name | City | State |
---|---|---|---|
United States | AHN CI Exercise Oncology and Resiliency Center | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via bioimpedance analysis | Measurement on bioimpedance analysis machine (Inbody 970) | 3 months | |
Primary | Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via ultrasound | Measurement via ultrasound and calculation with Jackson-Pollack calculations | 3 months | |
Primary | Determine changes in muscle mass in pounds from before to after the nutrition and exercise regimen | Measurement on bioimpedance analysis machine (Inbody 970) | 3 months | |
Secondary | Determine changes in overall score of functional movement screen (FMS) from before to after the nutrition and exercise regimen | Determine changes in overall score of functional movement screen (FMS) from before to after the nutrition and exercise regimen | 3 months | |
Secondary | Determine changes in Y-balance score for each leg | Y-balance score adds up the distance each leg can move in the front and side directions, divided by the length of the hip. This correlates inversely with fall risk. | 3 months | |
Secondary | Determine changes in strength via load measured in pounds from before to after the nutrition and exercise regimen | Load is calculated by multiplying sets by repetitions by weight lifted for a specific exercise | 3 months | |
Secondary | Determine changes in EQ-5D responses 1-5 and overall score from before to after the nutrition and exercise regimen | EQ-5D asks 5 questions rates from 1-5 and an overall rating of health | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|